Biotech Wrap: Human Sector not Getting Its Share –

Venture investors did not catch the fever of excitement surrounding the Human Genome Project.

Six months after the mapping of the human genome, investments in human biotechnology have accounted for only a paltry percentage of total venture investment in biotechnology. Year to date, companies dedicated exclusively to human biotechnology have accounted for only $126.39 million of the $2.96 billion total invested in biotechnology, according to our